000 02038nam  2200361zi 4500
0019.923957
003CaOODSP
00520230821154517
006m     o  d f      
007cr cn|||||||||
008230616s2022    onca    o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aCC273-3/8-2021E-PDF
24500|aImpairment and the COVID-19 pandemic.
264 1|a[Ottawa] : |bCanadian Centre for Occupational Health and Safety, |c[2022]
300 |a1 online resource (3 unnumbered pages) : |billustrations.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |a[COVID-19 health and safety resources]
500 |aCaption title.
500 |aIssued also in French under title: Facultés affaiblies et pandémie de COVID-19.
520 |a"In Canada, the COVID-19 pandemic has created an unprecedented challenge that has changed the way that we live and work. One of the indirect impacts of the COVID-19 pandemic in Canada is a possible increase in the use of substances (e.g. the use of prescription drugs, alcohol, cannabis, illegal drugs) to cope with the stress of the pandemic. This document provides employers and employees with an introduction to workplace impairment, with a focus on substance use during the pandemic. General recommendations are outlined for implementing a workplace impairment program"--Introduction.
650 0|aCOVID-19 (Disease)|zCanada|xPsychological aspects.
650 0|aIndustrial hygiene|zCanada.
650 0|aSubstance abuse|zCanada.
7102 |aCanadian Centre for Occupational Health and Safety, |eissuing body.
77508|tFacultés affaiblies et pandémie de COVID-19.|w(CaOODSP)9.926322
830#0|aCOVID-19 health and safety resources.|w(CaOODSP)9.923788
85640|qPDF|s125 KB|uhttps://publications.gc.ca/collections/collection_2023/cchst-ccohs/CC273-3-8-2021-eng.pdf
85641|qHTML|sN/A|uhttps://www.ccohs.ca/covid19/impairment/